But body contouring doesn't come cheap. The average price of a full-body lift is around $30,000. Arm surgery runs in the range of $8,000, while inner thighs cost about $10,000 a pair. A breast lift and upper back surgery will set you back about $15,000, and a neck and face lift would add another $15,000 to the bill. (As you probably already guessed, insurance rarely covers any of it.)
CoolSculpting is a procedure that eliminates stubborn fat safe and effectively, without any surgery or downtime. The CoolSculpting treatment is the only FDA-cleared procedure to use controlled cooling to safely target and eliminate fat that is resistant to diet and exercise. With over 5 million treatments performed, the results are proven, noticeable and lasting. We can help you Achieve your goal of looking great at every angle.
The best candidates for CoolSculpting are within a healthy weight range, but have excess fat that creates an aesthetic disproportion and does not seem to respond to diet or exercise. To learn more about whether CoolSculpting is right for your needs, please contact our office today to set up your private consultation in the comfort and privacy of our NYC offices.
Scientific studies have shown that drinking 500 ml of water daily can increase the body’s metabolic rate by 30 percent. This is the driving force behind the science of body sculpting: body’s metabolism. Drinking a lot of water combined with the intake of composed proteins, and complex carbohydrates along with healthy fats is the quickest and surest way of boosting your body’s metabolism. This will help you achieve a unique physique with perfectly toned muscles.
Fodor is more enthusiastic about the LipoSonix technology. "I am very optimistic," he says." I love the results," he says citing as much as a 7-centimeter reduction in waist circumference seen in clinical trials conducted in Mexico. This technology, which uses high-intensity ultrasound waves, beamed about an inch under the skin to break up fatty tissue, has been studied in both pig models and in 33 people in Mexico, he says. The company has applied for FDA status to begin preclinical studies in the U.S. and expects such trials to begin in 2007.